Moxifcin Eye Drops Indications/Uses

Moxifcin Eye Drops is indicated for the treatment of patients 1 year of age and older with bacterial conjunctivitis caused by susceptible strains of the following organisms: Gram-positive bacteria: Corynebacterium species; Microbacterium species; Micrococcus luteus [including erythromycin, gentamicin, tetracycline, and/or trimethoprim resistant strains]; Staphylococcus aureus [including methicillin, erythromycin, gentamicin, ofloxacin, tetracycline and/or trimethoprim resistant strains]; Staphylococcus epidermidis [including methicillin, erythromycin, gentamicin, ofloxacin, tetracycline and/or trimethoprim resistant strains]; Staphylococcus haemolyticus [including methicillin, erythromycin, gentamicin, ofloxacin, tetracycline and/or trimethoprim resistant strains]; Staphylococcus hominis [including methicillin, erythromycin, gentamicin, ofloxacin, tetracycline and/or trimethoprim resistant strains]; Staphylococcus warneri [including erythromycin resistant strains]; Streptococcus mitis [including penicillin, erythromycin, tetracycline and/or trimethoprim resistant strains]; Streptococcus pneumoniae [including penicillin, erythromycin, gentamicin, tetracycline and/or trimethoprim resistant strains]; Streptococcus viridians [including penicillin, erythromycin, tetracycline and/or trimethoprim resistant strains].
Gram-negative bacteria: Acinetobacter species; Haemophilus "alconae" [including ampicillin resistant strains]; Haemophilus influenza [including ampicillin resistant strains]; Klebsiella pneumoniae; Moraxella catarrhalis; Pseudomonas aeruginosa.
*Other microorganisms: Chlamydia trachomatis.
Efficacy for this organism was studied in fewer than 10 infections Preoperative and postoperative sterilization (when prophylactic antibiotic treatment is required).